3.302 articles found

Quantitative assessment of the gait improvement effect of LSVT BIG® using a wearable sensor in patients with Parkinson's disease

Matsuno A, Matsushima A, Saito M, Sakurai K, Kobayashi K, Sekijima Y.

Heliyon · 2023-06-01

Identifying the potential role of serum miR-20a as a biomarker for olfactory dysfunction in patients with Parkinson's disease.

Liu H, Zhao H, Bao Y, Yang J, Xie H, Huang D.

Eur Arch Otorhinolaryngol · 2023-06-01

DOI: 10.1007/s00405-023-08034-5PMID: 37258792

Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson's disease based on integrative analysis.

Guo X, Hu W, Gao Z, Fan Y, Wu Q, Li W.

NPJ Parkinsons Dis · 2023-05-31

DOI: 10.1038/s41531-023-00527-8PMID: 37258507

The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker.

Michetti F, Clementi ME, Di Liddo R, Valeriani F, Ria F, Rende M, Di Sante G, Romano Spica V.

Int J Mol Sci · 2023-05-31

DOI: 10.3390/ijms24119605PMID: 37298554

Inflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative Disorders.

Pedersen CC, Ushakova A, Skogseth RE, Alves G, Tysnes OB, Aarsland D, Lange J, Maple-Grødem J.

Neurol Neuroimmunol Neuroinflamm · 2023-05-31

DOI: 10.1212/nxi.0000000000200132PMID: 37258413

Combining skin and olfactory α-synuclein seed amplification assays (SAA)-towards biomarker-driven phenotyping in synucleinopathies.

Kuzkina A, Rößle J, Seger A, Panzer C, Kohl A, Maltese V, Musacchio T, Blaschke SJ, Tamgüney G, Kaulitz S, Rak K, Scherzad A, Zimmermann PH, Klussmann JP, Hackenberg S, Volkmann J, Sommer C, Sommerauer M, Doppler K.

NPJ Parkinsons Dis · 2023-05-29

DOI: 10.1038/s41531-023-00519-8PMID: 37248217

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.

Okuzumi A, Hatano T, Matsumoto G, Nojiri S, Ueno SI, Imamichi-Tatano Y, Kimura H, Kakuta S, Kondo A, Fukuhara T, Li Y, Funayama M, Saiki S, Taniguchi D, Tsunemi T, McIntyre D, Gérardy JJ, Mittelbronn M, Kruger R, Uchiyama Y, Nukina N, Hattori N.

Nat Med · 2023-05-29

DOI: 10.1038/s41591-023-02358-9PMID: 37248302

(HIIT-The Track) High-Intensity Interval Training for People with Parkinson's Disease: Individual Response Patterns of (Non-)Motor Symptoms and Blood-Based Biomarkers-A Crossover Single-Case Experimental Design.

Gomes ESA, Van den Heuvel OA, Rietberg MB, De Groot V, Hirsch MA, Van de Berg WDJ, Jaspers RT, Vriend C, Vanbellingen T, Van Wegen EEH.

Brain Sci · 2023-05-24

DOI: 10.3390/brainsci13060849PMID: 37371330

Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson's disease.

Qu Y, Qin QX, Wang DL, Li JT, Zhao JW, An K, Li JY, Mao ZJ, Min Z, Xiong YJ, Xue Z.

Front Aging Neurosci · 2023-05-22

DOI: 10.3389/fnagi.2023.1130833PMID: 37284018

Author Correction: Gait improvement with wearable cyborg HAL trunk unit for parkinsonian patients: five case reports.

Uehara A, Kawamoto H, Imai H, Shirai M, Sone M, Noda S, Sato S, Hattori N, Sankai Y.

Sci Rep · 2023-05-22

DOI: 10.1038/s41598-023-35421-zPMID: 37217550

An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers.

Olson KE, Abdelmoaty MM, Namminga KL, Lu Y, Obaro H, Santamaria P, Mosley RL, Gendelman HE.

Transl Neurodegener · 2023-05-22

DOI: 10.1186/s40035-023-00361-1PMID: 37217980

Co-Designing Digital Technologies for Improving Clinical Care in People with Parkinson's Disease: What Did We Learn?

Monje MHG, Grosjean S, Srp M, Antunes L, Bouça-Machado R, Cacho R, Domínguez S, Inocentes J, Lynch T, Tsakanika A, Fotiadis D, Rigas G, Růžička E, Ferreira J, Antonini A, Malpica N, Mestre T, Sánchez-Ferro Á, iCARE-Pd Consortium.

Sensors (Basel) · 2023-05-22

DOI: 10.3390/s23104957PMID: 37430871